Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi‐center, single‐arm, open‐label, phase 2 study
暂无分享,去创建一个
Shunqing Wang | Jianda Hu | Yongping Song | C. Ji | Shenmiao Yang | Sujun Gao | Wei Zhang | J. Zhou | Zunmin Zhu | Wei Xu | Ting Liu | Xinran Tang | Lihong Liu | K. Ding | Huilai Zhang | Yan Li | K. Zhou | Yu Hu | Zhongjun Xia | Jianyong Li | Bing‐ling Xu | Tingyu Wang | Shuo Ma | Bin Zhang | Xin Wang